SLN Staging in Carcinoids and Neuroendocrine Tumors

  • A. Schauer
  • M. Schauer
  • U. Ritzel


Single Photon Emission Compute Tomography Sentinel Node Neuroendocrine Tumor Vasoactive Intestinal Peptide Carcinoid Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adams S, Baum R, Rink T, Schumm-Drager PM, Usadel KH, Hor G (1998a) Limited value of fluorine-18 fiuorodeoxy-glucose positron emission tomography for the imaging of neuroendocrine tumours. Eur J Nucl Med 25:79–83PubMedGoogle Scholar
  2. Adams S, Baum RE, Hertel A, Wenish HJ, Staib-Sebler E, Herrmann G, Enke A, Hor G (1998b) Intraoperative gamma probe detection of neuroendocrine tumors. J Nucl Med 39:1155–1160PubMedGoogle Scholar
  3. Ahlman H (1999) Surgical treatment of carcinoid tumors of the stomach and small intestine. Ital J Gastroenterol Hepatol 31[Suppl 2]:S198–S201PubMedGoogle Scholar
  4. Angelitti S, Corleto VD, Schillaci O, Moretti A, Panzuto F, Annibale B, Delle Fave G (1999) Single dose of octreotide stabilize metastatic gastro-entero-pancreatic endocrine tumors. Ital J Gastroenterol Hepatol 31:23–27PubMedGoogle Scholar
  5. Arrigoni MG, Woolner LB, Bernatz PE (1972) Atypical carcinoid tumours of the lung. J Thorac Cardiovasc Surg 64:413–421PubMedGoogle Scholar
  6. Aures D, Håkanson R, Schauer A (1968) Histidine decarboxylase and DOPA decarboxylase in the rat stomach. Properties and cellular localization. Eur J Pharmacol 3:217–234CrossRefPubMedGoogle Scholar
  7. Banzo J, Abos MD, Prats E, Delgado M, Razola P, Garcia S, Gomollon F, Garcia F (2001) The scintigraphy of somatostatin receptors in the carcinoid tumor. Rev Esp Med Nucl 20:11–18PubMedGoogle Scholar
  8. Bonato M, Cerati M, Pagani A, Papotti M, Bosi F, Bussolati G, Capella C (1992) Differential diagnostic patterns of lung neuroendocrine tumours. A clinico-pathological and immunohistochemical study of 122 cases. Virchows Arch [A] 420:201–211Google Scholar
  9. Bordi C (1999) Gastric carcinoids. Ital J Gastroenterol Hepatol 31[Suppl 2]:S94–S97PubMedGoogle Scholar
  10. Brandt-Mainz K, Müller SP, Gorges R, Sailer B, Bockisch A (2000) The value of fluorine-18 fluorodeoxyglucose PET in patients with medullary thyroid cancer. Eur J Nucl Med 27:490–496CrossRefPubMedGoogle Scholar
  11. Brundler R, Gebbers JO, Criblez D (1999) Multiple gastric carcinoid tumors in chronic atrophic gastritis: long-term follow-up under conservative management. Schweiz Med Wochenschr 129(25):957–960PubMedGoogle Scholar
  12. Capella C, Heitz P, Höfler H, Solcia E, Klöppel G (1995) Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 425:547–560CrossRefPubMedGoogle Scholar
  13. Casini Raggi C, Pinzani P, Gelmini S, Tricarico C, Orlando C, Calabro A, Renzi D, Cianchi F, Valanzano R, Distante V, Cortesini C, Tonelli F, Cataliotti L, Cameron Smith M, Messerini L, Bianchi S, Pazzagli M, Serio M, Maggi M (2001) Somatostatin receptors in non-endocrine tumors. Minerva Endocrinol 26:149–158PubMedGoogle Scholar
  14. Chatziioannou A, Kehagias D, Mourikis D, Antoniou A, Limouris G, Kaponis A, Kavatzas N, Tseleni S, Vlachos L (2001) Imaging and localization of pancreatic insulinomas. Clin Imaging 25(4):275–283CrossRefPubMedGoogle Scholar
  15. Conti PS, Durski JM, Bacqai F, Grafton ST, Singer PA (1999) Imaging of locally recurrent and metastatic thyroid cancer with positron emission tomography. Thyroid 9:797–804PubMedGoogle Scholar
  16. Debray MP, Geoffroy O, Laissy JP, Lebtahi R, Silbermann-Hoffman O, Henry-Reugeas MC, Cadiot G, Mignon M, Schouman-Claeys E (2001) Imaging appearance of metastases from neuroendocrine tumours of the pancreas. Br J Radiol 74(887):1065–1070PubMedGoogle Scholar
  17. Garza Trasobares E, Muniesa Soriano JA, Lazaro Maisonave JM (1999) Multicentric gastric carcinoid tumor. Rev Esp Enferm Dig 91(6):456–457PubMedGoogle Scholar
  18. Giammarile F, Baudin E, Tenenbaum F, Lumbroso J, Schlumberger M, Rougier P, Ruffle P, Guigay J, Ducreaux ML, Parmentier C (1995) Somatostatin receptor imaging: a preliminary experience in forty-nine patients. Q J Nucl Med 39(4) [Suppl 1]:121–123PubMedGoogle Scholar
  19. Gibril F, Reynolds JC, Lubensky IA, Roy PK, Peghini PL, Doppman JL, Jesen RT (2000) Ability of somatostatin receptor scintigraphy to identify patients with gastric carcinoids: a prospective study. J Nucl Med 41(10):1646–1656PubMedGoogle Scholar
  20. Giovannini M, Pasquier J, Brenot-Rossi I, Perrier H, Sauvan R, Seits JF (1995) The role of echoendoscopy and scintigraphy of somatostatin receptors in the staging of neuro-endocrine digestive tumors. Ann Gastroenterol Hepatol (Paris) 31(2):109–113Google Scholar
  21. Gould VER, Linnoila I, Memoli VA, Warren WH (1983) Neuroendocrine cells and neuroendocrine neoplasms of the lung. Lab Invest 49:519–539PubMedGoogle Scholar
  22. Herder WW de, Lamberts SW (2002) Somatostatin and somatostatin analogues: diagnostic and therapeutic uses. Curr Opin Oncol 14:53–57CrossRefPubMedGoogle Scholar
  23. Hoefnagel CA (1994) Metaiodobenzylguanidine and somatostatin in oncology: role in the management of neural crest tumours. Eur J Nucl Med 21:561–581PubMedGoogle Scholar
  24. Holler H (1997) Neuroendocrine Tumoren der Lunge (Neuroendocrine lung tumors). Verh Dtsch Ges Pathol 81:118–124PubMedGoogle Scholar
  25. Krenning EP, Kwekkeboom DJ, Bakker WH, Breeman WA, Kooij PP, Oei HY, Hagen M van, Postema PT, Jong M de, Reubi JC, Visser TJ, Reijs AEM, Hofland LJ, Koper JW, Lamberts SWJ (1993) Somatostatin receptor scintigraphy with (111In-DTPA-D-Phe 1)-and (123I-Tyr 3)-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 20:716–731CrossRefPubMedGoogle Scholar
  26. Kulaksiz H, Eissele R, Rossler D, Schulz S, Hollt V, Cetin Y, Arnold R (2002) Identification of somatostatin receptor subtypes 1, 2A, 3 and 5 in neuroendocrine tumors with subtype specific antibodies. Gut 50:52–60CrossRefPubMedGoogle Scholar
  27. Martelli H, Ricard M, Larroquet M, Wioland M, Paraf F, Fabre M, Josset P, Helardot PG, Gauthier F, Terrier-Lacombe MJ, Michon J, Hartmann O, Tabone MD, Patte C, Lumbroso J, Grüner M (1998) Intraoperative localization of neuroblastoma in children with I123 or I125 radiolabeled metaiodobenzylguanidine. Surgery 123:51–57CrossRefPubMedGoogle Scholar
  28. Ohrvall U, Westlin JE, Nilsson S, Juhlin C, Rastard J, Lundquist H, Akerstrom G (1997) Intraoperative gamma detection reveals abdominal endocrine tumors more efficiently than somatostatin receptor scintigraphy. Cancer 80(12) [Suppl]:2490–2494CrossRefPubMedGoogle Scholar
  29. Padberg BC, Städtler C, Schröder S (2000) Morphologic DNA-Zytophotometrie und Prognose gastrointestinaler neuroendokriner Tumoren (Karzinoide). Eine klinischpathologische Untersuchung an 95 Patienten. Pathologe 21:73–81CrossRefPubMedGoogle Scholar
  30. Papotti M, Croce S, Bello M, Bongiovanni M, Allia E, Schindler M, Mussolati G (2001) Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumors. Correlation with preoperative octreotide scintigraphy. Virchows Arch 439: 787–797PubMedGoogle Scholar
  31. Pasquali C, Rubello D, Sperti C, Gasparoni P, Lissi G, Chierichetti F, Ferlin G, Pedrazzoli S (1998) Neuroendocrine tumor imaging: can 18F-fluorodeoxyglucose positron emission tomography detect tumors with poor prognosis and aggressive behaviour? World J Surg 22:588–592CrossRefPubMedGoogle Scholar
  32. Peltier P, Curtet C, Chatal JF, le Doussal JM, Daniel G, Aillet G, Gruaz-Guyon A, Barbet J, Delaage M (1993) Radioimmunodetection of medullary thyroid cancer using a bispecific anti-CEA, anti-indium-DTPA antibody and an indium-111-labeled DTPA dimer. J Nucl Med 34:1267–1273PubMedGoogle Scholar
  33. Quaedvlieg PF, Visser O, Lamers CB, Janssen-Heijen ML, Taal BG (2001) Epidemiology and survival in patients with carcinoid disease in The Netherlands. An epidemiology study with 2391 patients. Ann Oncol 12:1295–1300CrossRefPubMedGoogle Scholar
  34. Schauer A, Aures D, Hakanson R, Clark WG (1968) Zellulare Lokalisation und physiologische Bedeutung von Aminosauredecarboxylasen. Verh Dtsch Ges Pathol 52: 356–361PubMedGoogle Scholar
  35. Seregni E, Ferrari L, Bajetta E, Martinetti A, Bombardieri E (2001) Clinical significance of blood chromogranin A measurement in neuroendocrine tumors. Ann Oncol 12[Suppl 23]:S69–S72CrossRefGoogle Scholar
  36. Soga J (1997) Gastric carcinoids: a statistical evaluation of 1094 cases collected from the literature. Surg Today 27: 892–901PubMedGoogle Scholar
  37. Stivanello M, Berruti A, Torta M, Termine A, Tampellini M, Gorzegno G, Angeli A, Dogliotti L (2001) Circulating chromogranin A in the assessment of patients with neuroendocrine tumors. A single institution experience. Ann Oncol 12[Suppl 2]:S73–S77CrossRefPubMedGoogle Scholar
  38. Tomassetti P, Migliori M, Caletti GC, Fusaroli P, Corinaldesi R, Gullo L (2000) Treatment of type II gastric carcinoid tumors with somatostatin analogues. N Engl J Med 343: 551–554CrossRefPubMedGoogle Scholar
  39. Travis W, Linnoila R, Tsokos M, Hitchcock C, Cutler G, Niemann L, Chrousos G, Pass H, Doppman J (1991) Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. Am J Surg Pathol 15(6):529–533PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • A. Schauer
  • M. Schauer
  • U. Ritzel

There are no affiliations available

Personalised recommendations